about
Structures of the lamin A/C R335W and E347K mutants: implications for dilated cardiolaminopathiesThe MOGE(S) Classification for a Phenotype-Genotype Nomenclature of Cardiomyopathy: Endorsed by the World Heart Federation.Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects.Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy.The pathologic basis of recovery.The MOGE(S) classification of cardiomyopathy for clinicians.Left Ventricular Noncompaction: A Distinct Genetic Cardiomyopathy?Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics.Familial dilated cardiomyopathy. Clinical and genetic characteristics.Autosomal recessive atrial dilated cardiomyopathy with standstill evolution associated with mutation of Natriuretic Peptide Precursor A.MOGE(S) nosology in low-to-middle-income countries.Aortic root 3D parametric morphological model from 2D-echo images.Transcriptomic and proteomic analysis in the cardiovascular setting: unravelling the disease?An International External Validation Study of the 2014 European Society of Cardiology Guideline on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (Evidence from HCM).Reply: The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: more questions than answers?Functionally Incomplete Re-Endothelialization of Stents and Neoatherosclerosis.Extracellular Volume in Dilated Cardiomyopathy: Interstitial Fibrosis and More?Common presentation of rare diseases: Aortic aneurysms & valves.Cardio-Oncology: The Carney Complex Type I.Endomyocardial Biopsy in acute cardiogenic shock: Diagnosis of pheochromocytoma.Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy.'Precision and personalized medicine,' a dream that comes true?Reply: A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation.Quantitative Expression of the Mutated Lamin A/C Gene in Patients With CardiolaminopathyThe MOGE(S) Classification for a Phenotype–Genotype Nomenclature of CardiomyopathyLong-Term Outcome and Risk Stratification in Dilated CardiolaminopathiesSupporting Translational Research on Inherited Cardiomyopathies through Information TechnologyRisk of dissection in thoracic aneurysms associated with mutations of smooth muscle alpha-actin 2 (ACTA2)Genetic causes of dilated cardiomyopathyRadiation Therapy for Head and Neck Cancer and AngioneogenesisGenetics and clinics: current applications, limitations, and future developmentsAnderson-Fabry diseaseLMNA Mutations Associated With Mild and Late-Onset Phenotype: The Case of the Dutch Founder Mutation p.(Arg331Gln)Correction: Age-specific reference values for carotid arterial stiffness estimated by ultrasonic wall trackingRenal and brain complications in GLA p.Phe113Leu Fabry disease. Comments on "Fabry disease caused by the GLA p.Phe113Leu (p.F113L) variant: Natural history in males" by Oliveira et al. (Eur. J. Med. Genet. 2019)Age-specific reference values for carotid arterial stiffness estimated by ultrasonic wall trackingCardiac Phenotypes in Hereditary Muscle Disorders: JACC State-of-the-Art Review
P50
Q27676832-F0E2BB79-6C29-4074-B7C5-833CBDCDFA7BQ30459441-EF9AA8BA-A8FB-4833-A526-2A2B254E5ED0Q33160368-621A1BFC-B198-481C-874B-31A5F030D706Q34980288-1A7ABD46-26A0-4F56-A6E3-61FC5F03EFCAQ38129035-28A4777E-C184-446E-A660-49139C4A9027Q38164909-5C7EB8BD-A864-4C1D-B997-A27453497C76Q38230674-E7C8B9E9-F60A-49EC-9E22-93C9798D642CQ38937285-0F3C61B1-E432-4D97-A3B8-8F5BCC3CFE23Q39431657-1522A8E1-4C58-4341-A76E-4529CD32078DQ39506391-F55A3367-5F37-4F99-BC99-C36E25BDF71DQ43900092-EE978652-0086-4085-9CB5-2A861BD50E6EQ44995800-A9DCB791-125C-4C0B-A5A5-C518E495C0EEQ45391732-020015CA-233A-4CAE-8B41-F379B917C733Q47779277-129CA266-FC74-49F4-90C1-8AA965D394BAQ48546767-4779D447-F8F2-4C3D-944E-25631E3CA7FEQ48606004-BC6D91DD-D5A6-400B-920F-57AEE6247AE9Q50162249-882E82D9-6DB4-4BC2-89D2-F5274B912C0EQ50188160-3143C69A-2534-4C58-9F8A-7A61AD593644Q52673426-EE7C8FA9-29BB-4696-AB97-B97008CA4D2DQ52872042-C181B1CB-44ED-45E7-B823-D159DD6DE6FBQ53307116-94EAB810-C39F-4E54-921C-89AB8A39B5DCQ53590387-FC9FC059-C7EC-4296-9641-5F8E55C805EDQ54184713-41343E2F-ABAF-4657-AC15-8B4B79D9CA2FQ54626974-67098083-BEAD-4938-AF9A-386A23D860EDQ56877622-FEA874B4-E4C0-43C6-A50A-0A773B2CEDCAQ56986168-E706C42D-D3D4-4B90-B8D5-6B219758D5BDQ57786298-0614A516-314C-4A1D-94F8-61B8C603B8F8Q58909661-B12B552E-F92B-415E-B193-BCF059B44A98Q58909934-DDD203D8-9150-4AB3-A4BB-7F015DDF54DBQ63198790-9BF46CBF-CB41-42B5-B4B7-52D94945AA24Q63198791-B4695844-87F5-4DB2-8135-35B09F09970CQ64101859-C5A1A7B5-40DC-4D5C-B5FF-CD2BFD53AD89Q88052203-54D54BAB-8CC1-450C-BE5A-87BCC1A1330DQ88724326-BBD33B83-D73E-43BD-8D96-475A8A58D123Q89455357-4785BFB7-C38A-4631-A32D-759EEA161B5EQ92691555-74DD2B43-235C-42DA-92AF-A04E0BDDC740Q92757799-5A2171D6-D05D-44C5-9FA9-58956A7B03CDQ93156821-419495EB-15D5-44A0-995A-A0B6267E7AB3
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Valentina Favalli
@ast
Valentina Favalli
@de
Valentina Favalli
@en
Valentina Favalli
@es
Valentina Favalli
@fr
Valentina Favalli
@nl
Valentina Favalli
@sl
type
label
Valentina Favalli
@ast
Valentina Favalli
@de
Valentina Favalli
@en
Valentina Favalli
@es
Valentina Favalli
@fr
Valentina Favalli
@nl
Valentina Favalli
@sl
prefLabel
Valentina Favalli
@ast
Valentina Favalli
@de
Valentina Favalli
@en
Valentina Favalli
@es
Valentina Favalli
@fr
Valentina Favalli
@nl
Valentina Favalli
@sl
P1053
P-7979-2016
P106
P1153
25122290300
P21
P31
P3829
P496
0000-0002-7058-6479